2161 Stock Overview
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 2161 from our risk checks.
JBM (Healthcare) Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.29 |
| 52 Week High | HK$1.38 |
| 52 Week Low | HK$0.86 |
| Beta | 0.28 |
| 11 Month Change | 31.63% |
| 3 Month Change | 43.33% |
| 1 Year Change | 15.18% |
| 33 Year Change | 46.59% |
| 5 Year Change | n/a |
| Change since IPO | -40.28% |
Recent News & Updates
Recent updates
JBM (Healthcare) Limited (HKG:2161) Stock Rockets 35% But Many Are Still Ignoring The Company
Nov 08
JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem
Dec 20Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors
Nov 01JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon
Jul 29Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings
Aug 03Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)
Jul 28Shareholder Returns
| 2161 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | -5.3% |
| 1Y | 15.2% | -8.3% | 11.3% |
Return vs Industry: 2161 exceeded the Hong Kong Pharmaceuticals industry which returned -8.3% over the past year.
Return vs Market: 2161 exceeded the Hong Kong Market which returned 11.3% over the past year.
Price Volatility
| 2161 volatility | |
|---|---|
| 2161 Average Weekly Movement | 8.4% |
| Pharmaceuticals Industry Average Movement | 6.7% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.1% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 2161 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2161's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 279 | Patrick Wong | www.jbmhealthcare.com.hk |
JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients.
JBM (Healthcare) Limited Fundamentals Summary
| 2161 fundamental statistics | |
|---|---|
| Market cap | HK$1.06b |
| Earnings (TTM) | HK$130.46m |
| Revenue (TTM) | HK$648.42m |
8.1x
P/E Ratio1.6x
P/S RatioIs 2161 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2161 income statement (TTM) | |
|---|---|
| Revenue | HK$648.42m |
| Cost of Revenue | HK$310.33m |
| Gross Profit | HK$338.08m |
| Other Expenses | HK$207.62m |
| Earnings | HK$130.46m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Nov 19, 2024
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 52.14% |
| Net Profit Margin | 20.12% |
| Debt/Equity Ratio | 11.3% |
How did 2161 perform over the long term?
See historical performance and comparison